Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;59(1):1256-1259.
doi: 10.1080/13880209.2021.1942924.

Pharmacokinetic study on the interaction between pachymic acid and bavachin and its potential mechanism

Affiliations

Pharmacokinetic study on the interaction between pachymic acid and bavachin and its potential mechanism

Jie Zhang et al. Pharm Biol. 2021 Dec.

Abstract

Context: Pachymic acid and bavachin are commonly used drugs in the therapy of lung cancer.

Objective: The co-administration of pachymic acid and bavachin was investigated to evaluate their potential drug-drug interaction.

Materials and methods: The pharmacokinetics of bavachin (10 mg/kg) was studied in male Sprague-Dawley (SD) rats in the presence of pachymic acid (5 mg/kg) (n = 6). The rats without pre-treatment of pachymic acid were set as the control and the pre-treatment of pachymic acid was conducted for 7 days before the administration of bavachin. The effect of pachymic acid on the activity of CYP2C9 was also estimated in rat liver microsomes with corresponding probe substrates.

Results: Pachymic acid influenced the pharmacokinetic profile of bavachin with the increased AUC (32.82 ± 4.61 vs. 19.43 ± 3.26 μg/L/h), the prolonged t1/2 (3.21 ± 0.65 vs. 2.32 ± 0.28 h), and the decreased CLz/F (307.25 ± 44.35 vs. 523.81 ± 88.67 L/h/kg) in vivo. The metabolic stability of bavachin was enhanced by pachymic acid and the transport of bavachin was inhibited by pachymic acid. Pachymic acid was found to inhibit the activity of CYP2C9 with the IC50 of 21.25 µM as well as the activity of P-gp.

Discussion and conclusion: The interaction between pachymic acid and bavachin results from the inhibition of CYP2C9 and P-gp. The dose of bavachin should be adjusted when combining with pachymic acid. The study design can be generalized to a broader study population with adjustment in the dose.

Keywords: CYP2C9; P-gp; drug-drug interaction.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest.

Figures

Figure 1.
Figure 1.
The mean plasma concentration-time curve of bavachin with or without the pre-treatment of pachymic acid. Pachymic acid significantly influenced the pharmacokinetic profile of bavachin.
Figure 2.
Figure 2.
Effect of pachymic acid on the transport of bavachin in Caco-2 model. Pachymic acid significantly inhibited the efflux of bavachin due to the decrease in the value of PappBA. ***p < 0.001.
Figure 3.
Figure 3.
Effect of pachymic acid on the activity of CYP2C9. Pachymic acid inhibited the activity of CYP2C9 in a dose-dependent manner with the IC50 value of 21.25 µM.

Similar articles

Cited by

References

    1. Alam F, Khan GN, Asad M.. 2018. Psoralea corylifolia L: ethnobotanical, biological, and chemical aspects: a review. Phytother Res. 32(4):597–615. - PMC - PubMed
    1. Balap A, Lohidasan S, Sinnathambi A, Mahadik K. 2017. Herb-drug interaction of Andrographis paniculata (Nees) extract and andrographolide on pharmacokinetic and pharmacodynamic of naproxen in rats. J Ethnopharmacol. 195:214–221. - PubMed
    1. Cai ZY, Sheng ZX, Yao H.. 2017. Pachymic acid ameliorates sepsis-induced acute kidney injury by suppressing inflammation and activating the Nrf2/HO-1 pathway in rats. Eur Rev Med Pharmacol Sci. 21(8):1924–1931. - PubMed
    1. Dechanont S, Maphanta S, Butthum B, Kongkaew C.. 2014. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 23(5):489–497. - PubMed
    1. Ding B, Ji X, Sun X, Zhang T, Mu S.. 2020. In vitro effect of pachymic acid on the activity of cytochrome P450 enzymes. Xenobiotica. 50(8):913–918. - PubMed

MeSH terms

LinkOut - more resources